As of Mar 24
| -0.30 / -0.18%|
The 21 analysts offering 12-month price forecasts for Amgen have a median target of 190.00, with a high estimate of 212.00 and a low estimate of 163.00. The median estimate represents a +14.64% increase from the last price of 165.74.
The current consensus among 27 polled investment analysts is to Buy stock in Amgen. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.